AI assistant
Sending…
Medpace Holdings, Inc. — Director's Dealing 2023
Apr 4, 2023
30442_dirs_2023-04-04_ba5cb636-9d99-436f-b661-d8d4fcc83e61.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2023-03-31
Reporting Person: McCarthy Cornelius P. III (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-31 | Common Stock | M | 82 | — | Acquired | 82 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | Restricted Stock Unit | $ | M | 82 | Disposed | Common Stock (82) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
F2: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, vesting in four equal installments on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.
More from Medpace Holdings, Inc.
Board/Management Information
2026
Jun 4
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 22
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 18